PubMed:20973483 / 0-112
Annnotations
LitCoin-entities
{"project":"LitCoin-entities","denotations":[{"id":"8197","span":{"begin":35,"end":71},"obj":"ChemicalEntity"},{"id":"8198","span":{"begin":92,"end":111},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"db_id","subj":"8197","obj":"MESH:D058915"},{"id":"A2","pred":"db_id","subj":"8198","obj":"MESH:D010300"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-sentences
{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":112},"obj":"Sentence"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin_Mondo
{"project":"LitCoin_Mondo","denotations":[{"id":"T1","span":{"begin":92,"end":111},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0005180"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-SeqVar
{"project":"LitCoin-SeqVar","denotations":[{"id":"T1","span":{"begin":45,"end":48},"obj":"SequenceVariant"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-GeneOrGeneProduct-v0
{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":49,"end":51},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":52,"end":60},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":61,"end":71},"obj":"GeneOrGeneProduct"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-GeneOrGeneProduct-v2
{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":52,"end":60},"obj":"GeneOrGeneProduct"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-Disease-MeSH
{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":92,"end":111},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"D010300"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin_Mondo_095
{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":92,"end":111},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0005180"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-MeSH-Disease-2
{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":92,"end":111},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D010300"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-MONDO_bioort2019
{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":92,"end":111},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"D010300"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-Chemical-MeSH-CHEBI
{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":35,"end":71},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"ChemicalEntity"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}
LitCoin-training-merged
{"project":"LitCoin-training-merged","denotations":[{"id":"T1","span":{"begin":35,"end":71},"obj":"ChemicalEntity"},{"id":"T76672","span":{"begin":92,"end":111},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T62420","span":{"begin":45,"end":48},"obj":"SequenceVariant"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"ChemicalEntity"},{"id":"A65895","pred":"#label","subj":"T76672","obj":"D010300"}],"text":"In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease."}